Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abbott Medical Optics (AMO), now a part of Johnson & Johnson Vision, is a global leader in ophthalmic healthcare specializing in cataract surgery, laser refractive surgery, and corneal care. The company's extensive portfolio includes the TECNIS family of intraocular lenses, the Catalys precision laser system for cataract procedures, and the STAR S4 IR excimer laser for LASIK. AMO also provides advanced diagnostic and wavefront-guided technologies, such as the iDesign Refractive Studio, to personalize vision correction. Beyond surgical equipment, the business offers consumer eye care products, including the Blink brand of lubricating eye drops. Originally established as a spinoff from Allergan and later acquired by Abbott Laboratories, the company was integrated into Johnson & Johnson following a $4.325 billion acquisition in 2017. Today, it continues to drive innovation in the surgical ophthalmology market, focusing on improving visual outcomes for patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abbott Medical Optics.